Wealthfront Corp: Form 10-Q for the period ended Jul 31, 2026
Filed with the SEC on Sep 14, 2026 and accepted by EDGAR at Sep 14, 2026, 20:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-05-01 to 2026-07-31 | $91.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2026-02-01 to 2026-07-31 | $182.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-05-01 to 2026-07-31 | $10.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2026-02-01 to 2026-07-31 | $20.7m | us-gaap:CostOfRevenue |
| Research and development | 3 months2026-05-01 to 2026-07-31 | $34.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2026-02-01 to 2026-07-31 | $67.7m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 3 months2026-05-01 to 2026-07-31 | $255.0k | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2026-02-01 to 2026-07-31 | $507.0k | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-05-01 to 2026-07-31 | $2.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2026-02-01 to 2026-07-31 | $7.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-05-01 to 2026-07-31 | $17.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2026-02-01 to 2026-07-31 | $30.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-05-01 to 2026-07-31 | $0.10 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2026-02-01 to 2026-07-31 | $0.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-05-01 to 2026-07-31 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2026-02-01 to 2026-07-31 | $0.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-05-01 to 2026-07-31 | 174,051,608 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2026-02-01 to 2026-07-31 | 174,050,331 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2026-02-01 to 2026-07-31 | $70.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 6 months2026-02-01 to 2026-07-31 | $60.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-07-31 | $453.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-07-31 | $1.65bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-07-31 | $1.78bn | us-gaap:Assets |
| Current liabilities | At period end2026-07-31 | $1.16bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-07-31 | $1.16bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2026-07-31 | $5.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2026-07-31 | $619.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-26-061848. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.